Multiple regions of E6AP (UBE3A) contribute to interaction with papillomavirus E6 proteins and the activation of ubiquitin ligase activity.

The HECT domain E3 ubiquitin ligase E6AP (UBE3A) is critical for the development of human papillomavirus (HPV) associated cancers, the neurodevelopment disorder Angelman Syndrome, and some cases of autism spectrum disorders. How E6AP recognizes its cellular targets and how its ubiquitin ligase activity is triggered remain poorly understood, and HPV E6 proteins are models for these processes. We examined diverse E6 proteins from human and non-human papillomaviruses and identified two different modes of interaction between E6 and E6AP. In Type I interactions, E6 can interact directly with the LXXLL peptide motif alone of E6AP (isolated from the rest of E6AP), and then recruit cellular substrates such as p53. In Type II interactions, E6 proteins require additional auxiliary regions of E6AP in either the amino terminus or in the carboxy-terminal HECT domain to interact with the LXXLL peptide motif of E6AP. A region of E6AP amino-terminal to the LXXLL peptide motif both augments association with E6 proteins and is required for E6 proteins to trigger ubiquitin ligase activity in the carboxy-terminal HECT ubiquitin ligase domain of E6AP. In Type I interactions, E6 can associate with E6AP and recruit p53, but a Type II interaction is required for the degradation of p53 or NHERF1. Interestingly, different E6 proteins varied in E6AP auxiliary regions that contributed to enhanced association, indicating evolutionary drift in the formation of Type II interactions. This classification of E6-E6AP interaction types and identification of a region in the E6AP amino terminus that is important for both E6 association and stimulation of ubiquitin ligase activity will inform future structural data of the E6-E6AP complex and future studies aiming to interfere with the activity of the E6-E6AP complex. Author summary The cellular HECT domain E3 ubiquitin ligase E6AP (UBE3A) associates with papillomavirus E6 oncoproteins, which contribute to 5% of cancer deaths world-wide. In addition, loss of E6AP causes the neurodevelopmental disorder Angelman Syndrome, and overexpression of E6AP causes some cases of autism spectrum disorders. How E6AP recognizes its cellular targets, and how E6AP ubiquitin ligase activity is triggered remain poorly understood. The interaction of HPV E6 proteins with E6AP are models for these processes as E6 both recruits substrates to E6AP and activates its ubiquitin ligase activity. This study utilizes a diverse panel of E6 proteins and E6AP mutants to identify regions of E6AP that contribute to both the interaction of E6 with E6AP and the activation of ubiquitin ligase activity by E6.